Search Login Register

Benign Fibrous Histiocytoma (Dermatofibroma) Summary

Description: A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)

Also Known As: Dermatofibroma; Dermatofibromas; Histiocytoma, Benign Fibrous; Angioma, Sclerosing; Angiomas, Sclerosing Show All >>

Networked: 355 relevant articles (7 outcomes, 29 trials/studies) for this Disease

Key Drugs and Agents for Benign Fibrous Histiocytoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Factor XIIIa : 2 outcomes 1 study in 32 results : IBA
  2. Dermatofibrosarcoma protuberans : 1 outcome 15 studies in 112 results : IBA
  3. Estrogens (Estrogen) : 1 outcome in 4 results : FDA 1
  4. dasatinib (BMS 354825) : 1 outcome in 1 result : FDA 2
  5. Muramidase (Lysozyme) : 2 studies in 10 results : IBA
  6. Paraffin : 1 study in 13 results : IBA
  7. Antigens : 1 study in 7 results : IBA
  8. Apoproteins : 1 study in 5 results : IBA
  9. Adenocarcinoma of lung : 1 study in 4 results : IBA
  10. malignant Schwannoma : 1 study in 4 results : IBA
Show All >>

Diseases Related to Benign Fibrous Histiocytoma

  1. Keloid
  2. Molluscum Contagiosum
  3. Malignant Fibrous Histiocytoma
  4. Sarcoma (Soft Tissue Sarcoma)
  5. Nevus (Nevi)
Show All >>

Key Therapies for Benign Fibrous Histiocytoma

Efficacy Chart >>
  1. Cryosurgery : 2 outcomes in 2 results
  2. Radiotherapy : 1 outcome in 4 results
  3. Complementary Therapies (Alternative Medicine) : 1 outcome in 1 result
  4. Drug Therapy (Chemotherapy) : 1 study in 5 results
  5. Mohs Surgery (Mohs' Micrographic Surgery) : 1 study in 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.